By leveraging the power of big data, egnite improves
patient care.
Clinical trials are necessary to ensure the safety and efficacy of new therapies, but they can be time-consuming, costly and inefficient to enroll, slowing down access to lifesaving treatment options. The future of faster clinical trials is here.
Partnership aims to understand the care paradigm and associated outcomes for patients with aortic regurgitation. First study presented by Nick Amoroso, MD, at the TVT Structural Heart Summit in Phoenix, Arizona.
Study Led by John Mignone, M.D., Ph.D., Presented at the Heart Rhythm Society’s Annual Meeting. Key Findings Demonstrate Increased Survival for Patients Receiving Combined Device and 4-Class Medical Therapy.
© 2022 egnite, Inc. All Rights Reserved. egnite, egnite Inc., and the stylized logo are trademarks of egnite, Inc. All other trademarks are property of their respective owners.